布地奈德联合利巴韦林 氨溴索雾化吸入治疗毛细支气管炎的疗效观察

目的观察布地奈德联合利巴韦林、氨溴索雾化吸人治疗毛细支气管炎的疗效。方法将我院160例毛细支气管炎患儿随机分为观察组和对照组，每组80例。两组均给予常规治疗，观察组在常规治疗的基础上给予布地奈德联合利巴韦林、氨溴索雾化吸人治疗，观察两组的临床效果。结果观察组显效率为90．0％，总有效率为100．0％，明显高于对照组的51．3％和78．8％（P〈0．01）；观察组临床症状、体征恢复时间均较对照组明显缩短（P〈0．01）。结论布地奈德联合利巴韦林、氨溴索雾化吸人治疗毛细支气管炎疗效显著，有推广价值。

Analysis of curative effect of aerosal inhalation of budesonide combinecl with ribavirin and ambroxol in the treatment of bronchiolitis

Objective To explore the curative effect of aerosal inhalation of budesonide combined with riba- virin and ambroxol in the treatment of bronchiolitis. Methods One hundred and sixty patients with bronchiolitis wererandomly divided into two groups, with 80 patients in each group. Two groups were given the conventional treatment. On the basis of above treatment, a group （ observation group） was treated with aerosal inhalation of budesonide com- bined with ribavirin and ambroxol. The carative effects of two groups were analyzed. Results The obvious effective rate and total effective rate in a group was 90.0% and 100. 0% respectively, those in B group was 51.3% and 78.8% respectively. There were statistically significant difference between tow groups （P 〈 0. 01 ）. The recovery time of symptoms and signs in A group were less than those in B group （P 〈 0. 01 ）. Conclusion Aerosal inhalation of budesonide combined with ribavirin and ambroxol in the treatment of bronchiolitis has significant effect and is worth popularizing.